Cosyne Therapeutics
@CoSyneTx
Precision medicine through polymathic AI
July is all about #Glioblastoma—deadliest brain cancer, no cure, no early detection. 💔 But there's hope. Join us this month as we spotlight the latest in GBM treatment & honor those we’ve lost. PLEASE RETWEET AND SPREAD THE WORD 🧠💙 🔗 abta.org/glioblastoma
Discover the latest advancements in our research and development pipeline. Monitor our progress and future of our drug programs. Check it out here: bit.ly/4e4ADH0 $CNSP #GlioblastomaMultiforme #Oncology #GBM
It's wonderful to see this significant advancement in the treatment of patients with GBM!
In memory of my sister Margaret, we launched a Glioblastoma drug trial. Now, Margaret’s Trial is open on the NHS - and offering real hope. Ben, diagnosed with a Glioblastoma in 2022, saw his tumour vanish. His story helped make this happen. Watch here:
In memory of my sister Margaret, we launched a Glioblastoma drug trial. Now, Margaret’s Trial is open on the NHS - and offering real hope. Ben, diagnosed with a Glioblastoma in 2022, saw his tumour vanish. His story helped make this happen. Watch here:
Remarkable advances in unraveling the brain's biology!
Combined single-cell profiling of chromatin–transcriptome and splicing across brain cell types, regions and disease state go.nature.com/3IKlcJn
Today is #WorldBrainDay—a reminder to protect, understand & care for our most complex organ. 🧠 Together, we honor the brain, and the brave people fighting to heal it.
CoSyne Therapeutics is committed to advancing new treatment options for glioblastoma patients. Read more about our work on our website: cosyne.com #CoSyneTherapeutics #Glioblastoma #BrainCancerResearch #DrugDiscovery #BioTech

Impressive effort underway in advancing drug discovery
Congrats to Dr. A. Mistry & his team of researchers for creating the world’s largest brain tumor database to speed treatment discovery. Click below to read more about the database. #UofLNeurosurgery #NeuroOncology @uofl @UofLMedSchool @UofLHealth uoflnews.com/section/scienc…